Compound ID | 3499
Class: Nucleotide synthesis inhibitor
| Spectrum of activity: | Gram-positive & Gram-negative |
| Details of activity: | Active against Staphylococcus aureus, Escherichia coli, and Acinetobacter baumannii; targets the bacterial inosine-5'-monophosphate dehydrogenase (GuaB) enzyme involved in guanine nucleotide synthesis |
| Propensity to select resistant mutants: | Low, at 10^-11 at 4-8xMIC |
| Description: | Synthetic compound; rational structure-based drug design; shows low cytotoxicity towards human inosine-5'-monophosphate dehydrogenase (50 uM vs MIC 0.00014~0.48); shows dose-dependent efficacy against Acinetobacter baumannii infection in neutropenic thigh model |
| Year first mentioned: | 2024 |
| Development status: | Experimental |
| Chemical structure(s): | |||||||||||
|
|
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/172640706 |
| Citation: | https://journals.asm.org/doi/10.1128/mbio.00897-24 |